Autoimmune hepatitis induced by adalimumab with successful switch to abatacept

Eur J Clin Pharmacol. 2012 May;68(5):895-8. doi: 10.1007/s00228-011-1191-4. Epub 2011 Dec 29.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Abatacept
  • Adalimumab
  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy
  • Chemical and Drug Induced Liver Injury / drug therapy
  • Chemical and Drug Induced Liver Injury / etiology*
  • Drug Monitoring
  • Drug Therapy, Combination / adverse effects
  • Female
  • Hepatitis, Autoimmune / drug therapy
  • Hepatitis, Autoimmune / etiology*
  • Humans
  • Immunoconjugates / therapeutic use*
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Immunoconjugates
  • Tumor Necrosis Factor-alpha
  • Abatacept
  • Adalimumab